495
Vandetanib, >99% Free Base | BC098-050/BC098-100
- SKU:
- 495-BC098-050/495-BC098-100
- Availability:
- IN STOCK
Description
Vandetanib, >99% Free Base | BC098-050/BC098-100 | Gentaur UK, US & Europe Distribution
Related Products
Vandetanib, >100% Free Base | BC098-500
495
NULL823.00
Vandetanib, >100% Free Base | BC098-500 | Gentaur UK, US & Europe Distribution
495-BC098-500
SB 202190, >99% Free Base | BC086-025/BC086-050
495
NULL282.00 - NULL337.00
SB 202190, >99% Free Base | BC086-025/BC086-050 | Gentaur UK, US & Europe Distribution
495-BC086-025/495-BC086-050
SB 203580, >99% Free Base | BC087-025/BC087-050
495
NULL337.00 - NULL398.00
SB 203580, >99% Free Base | BC087-025/BC087-050 | Gentaur UK, US & Europe Distribution
495-BC087-025/495-BC087-050
AMPLIRUN® Western equine encephalitis RNA Control | MBC098
VRC
NULL400.00
AMPLIRUN® Western equine encephalitis RNA Control | MBC098 | Gentaur UK, US & Europe Distribution AMPLIRUN® WESTERN EQUINE ENCEPHALITIS RNA CONTROL Purified Western equine encephalitis virus...
VRC-MBC098-GEN
LY 294002, >99% | BC051-050/BC051-100
495
NULL282.00 - NULL398.00
LY 294002, >99% | BC051-050/BC051-100 | Gentaur UK, US & Europe Distribution
495-BC051-050/495-BC051-100
Vandetanib | 1751
26
NULL347.00 - NULL675.00
A potent inhibitor of kinase insert domain-containing receptor [KDR/vascular endothelial growth factor receptor (VEGFR) 2] tyrosine kinase activity (IC₅₀ = 40 nM). This compound also inhibits...
26-1751-GEN
SP600125, >99% | BC089-050/BC089-100/BC089-500
495
NULL298.00 - NULL645.00
SP600125, >99% | BC089-050/BC089-100/BC089-500 | Gentaur UK, US & Europe Distribution
495-BC089-050/495-BC089-100/495-BC089-500